Skip to content

Transforming your biomedical data into actionable insights

We are your agile data science partner with expertise in biomedical data analysis, data mining, data integration, pipeline development, machine learning and artificial intelligence, software engineering and more.

 

Who we work with

We support biotech, pharmaceutical and diagnostic companies, and research institutions of all sizes to enable truly data-driven discovery, preclinical, translational and clinical R&D processes. We also have robust experience working in the animal health field as well as in supporting food and agriculture R&D.

What we do

Leveraging our expertise in advanced bioinformatics, predictive analytics & AI, tailored software development, and data governance & architecture to support you in data-driven research and development and (pre)clinical studies.

Learn more →

BioLizard provided a highly professional and skilled deliverable to our request. The outcome and analysis of the hypothesis will help us in the decision-making process to identify an efficient strategy for further development of the drug product.


- Sillar Clinical

idea2 Tailored solutions

We help you make better, more data-driven decisions faster. Our goal? Supporting you in getting the most out of your biomedical data.

 

Bio|Verse platform               

We strongly believe that creating data-driven biological insights requires a combination of computational power, human input and collaboration. 

datadriven Data-driven services

We are your agile data science partner with expertise in biomedical data analysis, data mining, pipeline development, AI and more.

 

Knowledge hub                  

We’re dedicated to fostering deep and broad expertise in our team of Lizards - and we’ve collected all our knowledge here for you to explore.

How we do it

BioLizard brings together a diverse yet complementary range of expertises to implement the most up-to-date technological tools to meet your unique data needs, now and in the future. We believe that an inclusive and open communication strategy with our clients is essential for the successful completion of each project. We ensure to align regularly with you throughout the process, and adjust pipelines to best fit your unique data case and maximize your output.

When you partner with BioLizard, you get state-of-the-art data analysis pipelines and tools to apply to your current and future research projects - and moreover, you receive end-to-end support that will make it faster and easier for you to turn your data into actionable insights. We also always ensure to fully explain our data science approach to solving your biological challenges - there’s no black box when you work with BioLizard.

 

how_we_work_graphic

A personalized, agile service model for truly impactful results

Join our webinar, Unlocking the spatial dimension: Maximizing insights from spatial omics data

On May 29th at 15:00 CEST, join us for an in-depth webinar delving into the cutting-edge realm of spatial omics technologies.

Experts from BioLizard and Pixelgen Technologies will guide you through how spatial omics can deepen your biological understanding by preserving spatial context within molecular analyses.

Register now →

Webinar-Banner_Pixelgen-BioLizard (1280 x 720 px) (Presentation)

Meet Liesbeth Ceelen and Matthew Hall at Swiss Biotech Day 2024

Liesbeth Ceelen, CEO, and Mathew Hall, BD Director, are attending Swiss Biotech Day from April 22nd-23rd. 

Connect with Liesbeth on LinkedIn →

Connect with Matthew on LinkedIn →

Matthew+LCL - SBD

BioLizard Appoints Matthew Hall as Director of Business Development

We are pleased to announce the appointment of Matthew Hall, PhD, as Director of Business Development. Matthew's regional insights, gained from more than a decade as an insider in the Swiss biotech sector, combined with his expertise in AI and biology, make him a perfect fit for the BioLizard team. His unique profile and global network will further empower the company to expand and strengthen its presence in Switzerland and other key markets.

Read more →

MHall-BioLizardprofilepic

Meet us at Amsterdam Chemistry Network's Chem Together #18

Volodimir Olexiouk, our Director of Scientific Engagement and AI & Analytics Team Lead, will speak at ACN's Chem Together #18 event with the focus: Unlocking AI-engineered medicines: from implementation to success.

Through practical strategies and real-life case studies, attendees will gain insights into accelerating drug discovery and optimizing operations with AI integration.

Register now →

ChemTogether18

BioLizard announces Swiss subsidiary

We are proud to announce that we have made an exciting new step in our continued international expansion, while deepening our commitment to our current and future Swiss partners and clients.

With the opening of our newest office at Biopôle Lausanne, we have officially entered the Swiss market. Biopôle, which houses 120 companies, provides the perfect conditions for us to engage with the Swiss biotech industry and offer our services exactly where our clients need them.

Read more →

Swiss subsidiary

BioLizard and AbnomX announce partnership

We are happy to announce our strategic partnership with AbnomX

BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data.

Read more →

BioLizard-Abnomx-Partnership

BioLizard featured on Data Science Leaders podcast

Volodimir Olexiouk, our Director of Scientific Engagement and Data Science Team Lead, was featured in episode 70 of Domino Data Lab's Data Science Leaders podcast.

In this episode, host Kjell Carlsson speaks with Volodimir about best practices for overcoming the data challenges for AI-driven drug discovery and combining scientific expertise with data science for augmented intelligence in the life sciences.

Listen now →

Domino Data Science Leaders Podcast episode 70

BioLizard featured in Trends 

BioLizard's role in head­ing digital transformation in the life ­sciences industry has been featured in the magazine Trends.

The article highlights BioLizard's proven expertise in supporting biotech and pharma with bioinformatics, data analytics, and leveraging of AI. 

Read more →

AI_blog2-small

BioLizard Highlighted at Bio-EUROPE

"It's not trivial to make sure that you have your data (management) right, to then be able to apply advanced analytics."

MC Services interviewed our BD Director Amparo Cuéllar at Bio-EUROPE. Check out the 2-minute video wherein she discusses:

  • The importance of ensuring that application of AI and other advanced analytics is grounded in an understanding of biology and your business strategy
  • Data analytics trends in the life sciences
  • What's next for BioLizard
  • Advice for companies who want to become more data-driven

Watch the 3-minute video →

Amparo_BioEurope

Trusted by

calypso-logo-2
cergentis-logo-2
cytura therapeutics logo-2
imec_logo-2
madam-therapeutics-logo-2
mdxhealth-logo-3
Pamgene-logo-2
pixelgen-logo-2
sillar-clinical-logo-1
U Ghent Vetrinary Sciences-2
Logo_EXO_Biologics
Rarety logo färg